1. Allyl trenbolone and flunixin meglumine treatment of mares with repeated embryonic loss
- Author
-
Kerstin Darenius, Hans Kindahl, and G. Fredriksson
- Subjects
endocrine system ,medicine.medical_specialty ,Pregnancy ,urogenital system ,business.industry ,Prostaglandin ,General Medicine ,Luteal phase ,medicine.disease ,chemistry.chemical_compound ,Endocrinology ,Embryonic Loss ,medicine.anatomical_structure ,chemistry ,FLUNIXIN MEGLUMINE ,Internal medicine ,medicine ,Gestation ,Allyl trenbolone ,business ,Corpus luteum ,reproductive and urinary physiology - Abstract
Summary Two mares being monitored in a project concerning early foetal death failed to maintain their pregnancies despite improved management. They repeatedly lost their conceptuses so one was treated with allyl trenbolone and the other with flunixin meglumine from Day 10 of gestation. Treatment with allyl trenbolone until Day 70 of gestation maintained pregnancy despite regression of the primary corpus luteum and the resulting low levels of endogenous progesterone in peripheral plasma during one month; secondary corpora lutea developed at the expected time. In the other mare with a history of premature release of prostaglandin F2α, treatment with flunixin meglumine until Day 60 of gestation inhibited prostaglandin F2α synthesis and luteal function was maintained.
- Published
- 2010